Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
3.040
+0.030 (1.00%)
At close: Nov 4, 2024, 4:00 PM
3.060
+0.020 (0.66%)
Pre-market: Nov 5, 2024, 8:21 AM EST

Trevi Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2016
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2016
Net Income
-38.77-29.07-29.15-33.94-32.76-26.05
Upgrade
Depreciation & Amortization
0.140.120.040.050.050.04
Upgrade
Other Amortization
0.390.570.520.60.23-
Upgrade
Loss (Gain) From Sale of Assets
-0.01----
Upgrade
Loss (Gain) From Sale of Investments
-1.54-2.13-0.83---
Upgrade
Stock-Based Compensation
2.912.252.332.542.421.13
Upgrade
Other Operating Activities
0.470.380.150.290.010.22
Upgrade
Change in Accounts Receivable
------0.37
Upgrade
Change in Accounts Payable
0.13-1.050.010.830.420.78
Upgrade
Change in Other Net Operating Assets
3.48-2.8-1.240.680.641.17
Upgrade
Operating Cash Flow
-32.79-31.71-28.18-28.95-29-23.09
Upgrade
Capital Expenditures
-0.07-0.14-0.16--0.03-0.01
Upgrade
Investment in Securities
25.5759.57-107.21---
Upgrade
Investing Cash Flow
25.559.43-107.37--0.03-0.01
Upgrade
Long-Term Debt Issued
----14-
Upgrade
Long-Term Debt Repaid
--9.5-5.83---
Upgrade
Net Debt Issued (Repaid)
-0.13-9.5-5.83-14-
Upgrade
Issuance of Common Stock
6.851.85117.4321.233.1865.14
Upgrade
Other Financing Activities
-0.23-0.26-0.29-0.45-0.46-1.89
Upgrade
Financing Cash Flow
6.5-7.91111.3120.7816.7273.21
Upgrade
Net Cash Flow
-0.7919.81-24.24-8.17-12.3150.11
Upgrade
Free Cash Flow
-32.86-31.85-28.33-28.95-29.03-23.1
Upgrade
Free Cash Flow Per Share
-0.33-0.32-0.44-1.27-1.61-1.97
Upgrade
Cash Interest Paid
0.180.330.590.60.18-
Upgrade
Levered Free Cash Flow
-19.17-21.97-17.95-16.5-16.62-13.69
Upgrade
Unlevered Free Cash Flow
-19.56-22.3-17.74-16.35-16.56-13.69
Upgrade
Change in Net Working Capital
-4.443.331.26-1.36-1.31-1.81
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.